Skip to main content
Clinical Trials/DRKS00024438
DRKS00024438
Not yet recruiting
Not Applicable

Optimization and evaluation of modern MRI techniques for acceleration and artifact reduction in pathologies of the skull base

Institut für Radiologie und Neuroradiologie Evangelisches Krankenhaus Oldenburg, Universitätsmedizin Oldenburg0 sites70 target enrollmentApril 8, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
isted exemplary ICH codes in an openly designed study, which covers a broader spectrum of skull base lesions: H.90.0 - H.90.8, H.91.0, H91.9, H93.8, H93.9, D33.1, D33.3, D33.7, D33.9, D32.9, D36.1, C.72.5
Sponsor
Institut für Radiologie und Neuroradiologie Evangelisches Krankenhaus Oldenburg, Universitätsmedizin Oldenburg
Enrollment
70
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 8, 2022
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Institut für Radiologie und Neuroradiologie Evangelisches Krankenhaus Oldenburg, Universitätsmedizin Oldenburg

Eligibility Criteria

Inclusion Criteria

  • General: persons with a minimum age of 18 years who are able to give their informed consent
  • Subproject 1 and 2, Step 1: Healthy Volunteers
  • Subproject 1, Step 2: Patients for CI evaluation (screening MRI examination for the exclusion of abnormalities of the auditory nerves, inner ears and central auditory path)
  • Subproject 2, Step 2: Patients with known or suspected untreated skull base lesions (e.g. vestibular Schwannomas, pseudotumors of the orbit, paragangliomas)

Exclusion Criteria

  • \- General MRI contraindications for MRI, e.g. implants such as non\-conditional MR\-suitable pacemakers or auto\-defibrillators, implanted neural stimulators and ocular metal foreign bodies (e.g. metal shards)
  • \- Conditions that could hinder the conduct of the study (e.B. morbid obesity, pronounced claustrophobia)
  • \- Existing unnecessary risks (pregnancy, surgery of an unsafe nature).
  • Subproject 1 and 2, Step 1: Known serious disease of the central nervous system.
  • Subproject 1, Step 2: Known serious disease of the central nervous system (other than possibly the one associated with hearing loss in the patient group).
  • Subproject 2, Step 2: Known serious disease of the central nervous system (except skull base lesions in the patient group)

Outcomes

Primary Outcomes

Not specified

Similar Trials